跳至主要内容
临床试验/NCT01466101
NCT01466101撤回不适用

Analgesic Effect of Pregabalin in Patients Undergoing Total Abdominal Hysterectomy

Northwestern University0 个研究点开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
主要终点
total hydromorphone consumption

研究概览

简要总结

Pregabalin will decrease the total amount of opioid required in patients undergoing total abdominal hysterectomy. In addition, pregabalin will decrease the incidence of opioid-related side effects in patients undergoing total abdominal hysterectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ASA Physical Status 1-2
  • Age 18-64
  • BMI 18-35
  • Scheduled for elective total abdominal hysterectomy (with or without bilateral salpingo-oophorectomy)
  • Gender: Female
  • Consent: Obtained

排除标准

  • Patient refusal
  • Allergy to study medication(s)
  • Preoperative use of gabapentinoids
  • Preoperative use of anticonvulsants
  • Daily use of analgesics
  • Hepatic disease
  • Renal insufficiency (Cr >2.0)
  • Alcohol or drug abuse
  • Pregnancy
  • Language: Non-English speaking
  • Patient expected to remain intubated after procedure
  • Patient request
  • Surgeon request
  • Allergic reaction to pregabalin
  • Surgical procedure significantly altered from scheduled procedure

研究组 & 干预措施

Pregabalin administration

Active Comparator

Administration of pregabalin

干预措施: Pregabalin administration (Drug)

Placebo

Placebo Comparator

Administration of placebo

干预措施: Placebo administration (Drug)

结局指标

主要结局

total hydromorphone consumption

时间窗: 24 hours

total hydromorphone consumption 24 hours post operatively

次要结局

  • Pain Scores postoperative(Post operative period)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christian Altman

Principal Investigator

Northwestern University

相似试验